Filter News
Area of Research
- Advanced Manufacturing (7)
- Biology and Environment (25)
- Clean Energy (64)
- Energy Frontier Research Centers (1)
- Fusion and Fission (10)
- Fusion Energy (2)
- Isotopes (1)
- Materials (53)
- Materials for Computing (5)
- National Security (5)
- Neutron Science (43)
- Nuclear Science and Technology (6)
- Supercomputing (21)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (43)
- (-) Advanced Reactors (10)
- (-) Bioenergy (23)
- (-) Climate Change (22)
- (-) Decarbonization (19)
- (-) Fusion (14)
- (-) Grid (15)
- (-) Nanotechnology (26)
- (-) Neutron Science (49)
- Artificial Intelligence (31)
- Big Data (7)
- Biology (21)
- Biomedical (17)
- Biotechnology (7)
- Buildings (13)
- Chemical Sciences (28)
- Clean Water (2)
- Composites (10)
- Computer Science (58)
- Coronavirus (17)
- Critical Materials (11)
- Cybersecurity (17)
- Education (3)
- Element Discovery (1)
- Energy Storage (42)
- Environment (35)
- Exascale Computing (9)
- Fossil Energy (1)
- Frontier (15)
- High-Performance Computing (28)
- Isotopes (18)
- ITER (2)
- Machine Learning (13)
- Materials (57)
- Materials Science (50)
- Mercury (2)
- Microelectronics (1)
- Microscopy (16)
- Molten Salt (2)
- National Security (18)
- Net Zero (3)
- Nuclear Energy (26)
- Partnerships (29)
- Physics (24)
- Polymers (12)
- Quantum Computing (9)
- Quantum Science (26)
- Renewable Energy (1)
- Security (11)
- Simulation (8)
- Space Exploration (3)
- Statistics (1)
- Summit (21)
- Sustainable Energy (30)
- Transformational Challenge Reactor (4)
- Transportation (25)
Media Contacts
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
Using the Titan supercomputer and the Spallation Neutron Source at the Department of Energy’s Oak Ridge National Laboratory, scientists have created the most accurate 3D model yet of an intrinsically disordered protein, revealing the ensemble of its atomic-level structures.
Craig Blue, a program director at the Department of Energy’s Oak Ridge National Laboratory, has been elected a 2019 fellow for SME (formerly known as the Society for Manufacturing Engineers).
Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.
Collaborators at the Department of Energy’s Oak Ridge National Laboratory and U.S. universities used neutron scattering and other advanced characterization techniques to study how a prominent catalyst enables the “water-gas shift” reaction to purify and generate hydrogen at industrial scale.
A team of scientists led by Oak Ridge National Laboratory have discovered the specific gene that controls an important symbiotic relationship between plants and soil fungi, and successfully facilitated the symbiosis in a plant that
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
OAK RIDGE, Tenn., May 14, 2019—Advanced Research Systems, Inc., has licensed a technology designed to automatically refill liquid helium used in laboratory equipment for low-temperature scientific experiments, which will reduce downtime, recover more helium and increase overall efficiency.
OAK RIDGE, Tenn., May 8, 2019—Oak Ridge National Laboratory and Lincoln Electric (NASDAQ: LECO) announced their continued collaboration on large-scale, robotic additive manufacturing technology at the Department of Energy’s Advanced Manufacturing InnovationXLab Summit.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.